1
Clinical Trials associated with SSGJ-709A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients With Advanced Malignant Tumors
This study is an open-label phase I study to evaluate the safety, pharmacokinetics, and anti-tumor activity of SSGJ-709 as a single agent in patients with advanced malignancies.
100 Clinical Results associated with SSGJ-709
100 Translational Medicine associated with SSGJ-709
100 Patents (Medical) associated with SSGJ-709
100 Deals associated with SSGJ-709